Top Markets
Coin of the day
Dr. Agarwal's Health Care Limited Dr. Agarwal's Health Care Limited

Dr. Agarwal's Health Care Limited

AGARWALEYE
Rankning i aktier #7063
Dr. Agarwal's Health Care Limited manages a chain of eye hospitals both within... Dr. Agarwal's Health Care Limited manages a chain of eye hospitals both within India and abroad. The company delivers a comprehensive range of ophthalmic services, including advanced surgical solutions for cataracts like small incision, phacoemulsification, robotic, and glued intraocular lens procedures. It also offers refractive surgeries designed to correct visual errors, thereby lessening or removing the necessity for glasses and contact lenses. Additional surgical specialties include treatments for retinal conditions, corneal transplantation, pinhole pupilloplasty, oculoplasty, and operations for glaucoma and pterygium. Beyond surgical interventions, the company provides professional medical consultations, in-depth diagnostic services for various eye disorders, and non-surgical therapies such as retinal laser treatment and dry eye management. Furthermore, Dr. Agarwal's Health Care Limited sells optical goods, including spectacles, lenses, contact lenses, and frames, as well as a variety of pharmaceutical products for eye care. The company was founded in 2010 and is based in Chennai, India.
Aktiekurs
$5.48
Marknadsvärde
$1.74B
Förändring (1 dag)
-0.10%
Förändring (1 år)
9.22%
Land
IN
Handel Dr. Agarwal's Health Care Limited (AGARWALEYE)

Kategori

Utdelningsavkastning för Dr. Agarwal's Health Care Limited (AGARWALEYE)
Utdelningsavkastningen (TTM) för Dr. Agarwal's Health Care Limited (aktiesymbol: AGARWALEYE) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Dr. Agarwal's Health Care Limited (AGARWALEYE) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter